Page last updated: 2024-09-05

lasofoxifene and Adverse Drug Event

lasofoxifene has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gennari, L; Merlotti, D; Nuti, R1

Reviews

1 review(s) available for lasofoxifene and Adverse Drug Event

ArticleYear
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene.
    Clinical interventions in aging, 2010, Feb-02, Volume: 5

    Topics: Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Osteoporosis, Postmenopausal; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes

2010